Navigation Links
New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting
Date:4/9/2008

BOSTON, April 9, 2008 /PRNewswire/ -- New devices and research for mechanical circulatory support in pediatrics from the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Pediatric Circulatory Support Program will be discussed at the International Society for Heart and Lung Transplantation (ISHLT) 28th Annual Meeting and Scientific Sessions. The meeting is ongoing this week at the Boston Marriott Copley Place and Hynes Convention Center.

The use of mechanical circulatory support devices (MCSDs) is shown to decrease wait list mortality and improve efficiency of organ utilization in children. Close to 1,800 children with congenital heart defects die each year, and 25 percent of the 36,000 babies born with these malformations require invasive treatment within the first year of life. Despite rapid technologic advances that have allowed development of sophisticated MCSDs for adults, very few such options exist for infants and children in need of mechanical circulatory support.

Acknowledging this vacancy, the NHLBI Pediatric Circulatory Support Program awarded five contracts to develop a family of devices. These include:
-- An implantable mixed-flow ventricular assist device designed

specifically for patients up to two years of age

-- Another mixed-flow ventricular assist device that can be implanted

intravascularly or extravascularly depending on size

-- Compact integrated pediatric cardiopulmonary assist systems

-- Apically implanted axial-flow ventricular assist device

-- Pulsatile-flow ventricular assist device.

"The field of pediatric mechanical circulatory support received a boost from the NHLBI program even beyond the much needed support for the development of these innovative new devices. There is a real sense of momentum in this field and the NHLBI program is largely responsible for this," said Brian Duncan, M.D., Pediatric and Congenital Heart Surgery, Children's Hospital, Cleveland Clinic.

At this year's meeting, Dr. Duncan will present data on the progress in development of each device. Because the program has reached its fifth year, the devices should soon be reaching the clinical trial phase, which Dr. Duncan will discuss as well.

About ISHLT

The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit organization dedicated to the advancement of the science and treatment of end-stage heart and lung diseases. Created in 1981, the society now includes more than 2,300 members from more than 45 countries, representing a variety of disciplines involved in the management and treatment of end-stage heart and lung disease.

ISHLT maintains two vital databases. The international Heart and Lung Transplant Registry is a one-of-a-kind registry that has been collecting data since 1983 from 223 hospitals from 18 countries. The ISHLT Mechanical Circulatory Device (MCSD) database has been collecting data since 2002 with the aim of identifying patient populations who may benefit from MCSD implantation; generating predictive models for outcomes; and assessing the mechanical and biological reliability of current and future devices. In Fall 2006 ISHLT released the first international guidelines for heart failure patient management. For more information, visit http://www.ishlt.org.

Contact: Lauren Mason

(210) 857-2521

lmason@masonpr.com


'/>"/>
SOURCE International Society for Heart and Lung Transplantation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research
2. SpineMark Partners With Regional Spine Leaders to Launch Its First Multisite Spine Research Organizations in Los Angeles, Denver
3. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
4. Navigenics(TM) Genome Analysis Used In Research Trial on the Impact of Providing Genetic Risk Assessments
5. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
6. ACORNs Oncology-focused Contract Research Organization Exceeds Projections
7. Low Acid Coffee Backed By Scientific Research
8. Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimers Disease
9. Stem Cell Research Provides Medical Breakthrough to Repair Heart Cell Damage Created by a Heart Attack
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
11. Velos to Develop Key System Interface for Clinical Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... PARK RIDGE, Ill. and INDIANAPOLIS ... caliber of students receiving a Lilly Diabetes Tomorrow,s Leaders ... hands. The 2016 scholarship winners, announced today online at ... refused to let type 1 diabetes stand in the ... Lilly Diabetes has supported the Foundation,s scholarship program since ...
Breaking Medicine Technology:
(Date:6/27/2016)... (PRWEB) , ... June 27, ... ... in the patient payment industry today announced its strategic partnership with Connance, ... system workflows. , The two companies’ proven, proprietary technology combine to provide ...
(Date:6/26/2016)... California (PRWEB) , ... June 26, 2016 , ... Pixel ... Cut Pro X. , "Film editors can give their videos a whole new perspective ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
Breaking Medicine News(10 mins):